Pharmacy

LO1. Interpret, relate, transfer and apply knowledge from the basic natural and medical sciences to the extent that enables a scientific approach in solving professional pharmaceutical issues.

LO2. List and describe the phases of the pharmaceutical product life cycle with special emphasis on the drug development phase and contrast them with the knowledge acquired through basic and professional disciplines.

LO3.   Define, explain and apply professional and scientific evidence and basic models, principles and procedures in pharmacotherapy and integrated pharmaceutical care.

LO4.   Explain, evaluate and apply the current legal provisions and professional guidelines in the field of healthcare, health insurance, pharmacy, medicines and medical products and specific health and non-health activities integrated into the field of pharmacy.

LO5. Interpret and apply scientific evidence on the pharmaceutical quality, safety and efficacy of drugs and classify drugs in accordance with the anatomical-therapeutic-

chemical classification and the method and place of issuance.

LO6.   Explain and evaluate the mechanism and therapeutic outcome of the drug, therapeutic indications, dosage and side effects.

LO7.   Interpret and apply pharmacogenomics in pharmacotherapy and the principles of personalised medicine, especially with biologic and other drugs for precise and targeted individualised therapy.

LO8.   Define, explain and apply evidence and good practice in pharmaceutical, non-clinical and clinical drug trials, development of active substance and finished medicine, production and quality control of medicines, production of galenic and magistral medicines, and storage and distribution of medicines.

LO9.   Explain and evaluate the indications and method of application of medical products and explain the use of other health products (food supplements, cosmetics, biocides, etc.) in health interventions and self-medication.

LO10. Examine and analyse pharmacoepidemiologic and pharmacoeconomic data in order to assess the treatment outcome and overall rational pharmaceutical care.

LO11. Interpret and apply relevant ethical, deontologic and business guidelines, practices and principles of organisation, management and administration in the pharmaceutical and industrial pharmaceutical business.

LO12. Develop a risk management plan and design pharmaceutical processes and procedures for: pharmaceutical interventions, drug research and development, production and quality control, storage and management of stocks and wholesale and retail trade for continuous supply of quality, safe and effective drugs and medical devices.

LO13. Review and evaluate the pharmacotherapeutic history and treatment plan and implement education and consultation with the patient to achieve the expected clinical treatment outcome and in solving therapeutic problems in terms of preventing side effects and drug interactions.

LO14. Calculate and control the drug dose/dosage and the formulation of the pharmaceutical form, as well as the method of drug administration, especially in therapeutically specific conditions, and diseases and specific groups of patients.

LO15. Manage the processes of controling responsible and rational use of medicines and medical products and implement non-pharmacologic measures to preserve health and prevent diseases, including the prevention of specific malnutrition.

LO16. Examine and report suspected side effects / adverse events in drug therapy, medical devices and dietary supplements, and identify and report quality defects and suspected counterfeits, prevent and revise uncritical polypharmacy in therapy.

LO17. Research and apply pharmacopoeia and other internationally accepted monographs, quality requirements, standards, regulations, procedures and good practice in the development and quality control of active and inactive ingredients, pharmaceutical containers and drugs (finished, galenic and magistral), as well as the pharmaceutical marketing.

LO18. Research and select professional and health registers/databases in the standardisation of guidelines and therapeutic categorisation of specific health conditions and forms of pharmaceutical interventions (neoplasms, childhood, old age, people with impaired or dysfunctional vital organs, etc.).

LO19. Judge, consider and implement the functional forms and content of interdisciplinary cooperation and good practice of multidisciplinary teams at all levels of healthcare, in the implementation and design of public health projects and public health campaigns and in scientific research.

LO20. Establish a quality assurance system, design and develop standard operating procedures for work in the pharmacy and at the manufacturer, including internal control, self-inspection and procedures in case of defects and product complaints, and implement corrective and preventive actions accordingly.

LO21. Establish a pharmacovigilance system for the marketing authorisation holder and collect and analyse all new scientific discoveries on the medicinal product.

LO22. Analyse the pharmaceutical market, examine trends in consumption and report it to the competent authorities, devise methods of advertising and informing about medicines, formulate the price of the medicine and devise a strategy for putting the medicine on the list.

LO23. Assess and decide on the rationality, justification and safety of pharmacotherapy based on knowledge and evidence and the contribution of pharmaceutical care to the treatment outcome and health preservation.

LO24. Assess and apply specific pharmaceutical care and pharmacotherapy in the treatment of certain therapeutically demanding diseases and in specific groups of patients.

LO25. Autonomously and ethically make decisions and conclusions in the fields of research and development, testing, production, quality control and drug marketing and other components of pharmaceutical activity and environmental protection in accordance with legislation and guidelines of good pharmaceutical practice.

LO26. Assess, evaluate and develop the principles of professional ethics and deontology in all substantive forms of pharmacy / pharmaceutical activity and make decisions in accordance with personal authority and the best scientific evidence.

LO27. Evaluate the pharmaceutical, chemical, biologic, pharmacologic-toxicologic and clinical documentation on the medicinal product and decide accordingly on the approval/denial of the authorisation, renewal/amendment of the marketing authorisation for the medicinal product.

LO28. Establish a cause-and-effect relationship between the adverse reaction and the medicinal product, communicate with international bodies, assess the benefit-risk balance and propose measures to reduce the risk or withdraw the medicinal product from the market.

LO29. Communicate drug and health information to patients and other health and non-health professionals, regulatory bodies and the interested public in an appropriate manner.

LO30. Define, develop and apply specific forms of digital personal communication with the patient in order to identify pharmacotherapeutic intervention needs, prevent medication errors, report side effects, etc.

LO31. Identify personal areas of interest and participate in lifelong learning programmes.

LO32. Apply and develop educational and information content and forms of telepharmacy and telemedicine.

LO33. Employ learning styles and methods that enable postgraduate specialist and doctoral training in the field of biomedicine and health.